Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

NCT00764868 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

269

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Lisdexamfetamine Dimesylate (LDX)

Sponsor

Shire